EU Politicians Call For Compulsory Licensing, More Joint Procurement For COVID-19
Parliament Wants Stronger Role For EU In Health Affairs
A resolution adopted by the EU’s legislative body includes ways of making Europe more resilient to future pandemics and supply chain risks, and ensuring equitable access to affordable vaccines and medicines. Proposals from the European Parliament to share IP and knowledge have been welcomed by medicines access campaigners.
You may also be interested in...
EFPIA Rejects EU Calls To Relax IP Protections
State-imposed mechanisms such as compulsory licensing will discourage rather than encourage investment in R&D, says Europe’s research-based industry. It has also dismissed suggestions that Europe is too dependent on API supplies from third countries.
COVID-19: Gilead To Fill Remdesivir Supply Gap In EU
As the US firm prepares to ramp up production of the antiviral for use in coronavirus patients, a debate is growing over whether changes could be made to EU rules that prevent the importation of generic drugs produced under a compulsory license.
EU Drug Regulatory Network Faces Up To An Uncertain And Complex Future
Regulators have produced yet another strategy outlining the challenges and next steps for the European drug regulatory network as the network prepares for a future characterized by rapid developments in science and technology, medicines access issues, supply chain weaknesses and emerging health threats.